RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
|
AP24534; AP-24534; AP 24534; Ponatinib HCl; Ponatinib hydrochloride
|
||||||||||
Details:
Theoretical analysis
CAS NO.:1114544-31-8
Molecular Formula:C29H28ClF3N6O
Molecular Weight:569.02
Purity: > 98%
Solubility (R.T.: 25℃): DMSO
Stability: - 20℃ 2 years
Description
ponatinib, also known as AP24534 is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors. Ponatinib was approved in 2012.
Availability and price
Packing: 10mg/50mg/100mg/500mg/1g and we provide a variety of packaging.
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to sales@rechemscience.com
Quality control data
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days.
Related Products
